4-Hydroxytamoxifen attenuates methamphetamine-induced nigrostriatal dopaminergic toxicity in intact and gonadetomized mice
For individuals with preexisting conditions such as type 2 diabetes, this side effect may be particularly problematic
It functions as a dual GLP-1 and GIP agonist and reduces patient obesity by nearly 22.5% of their BW by 72 weeks in Phase III SURMOUNT-1 human trials
Federal health officials publicly signaled that most of those restricted peptides were expected to move back toward Category 1, which would restore the legal compounding pathway
Potential side effects can include bruising at the cannula site, a temporary drop in blood pressure (particularly with rapid magnesium delivery), nausea, or lightheadedness
These medications have been used for many years in both diabetes care and weight management, and patients often appreciate knowing whats typical, whats uncommon, and how to stay comfortable as the body adjusts